Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00978003 · ClinicalTrials.gov registry record

Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteer

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
28
Enrollment target

NCT00978003 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00978003 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
28 participants
Enrollment target

Study Summary

Background: * Patellofemoral pain syndrome is one of the most common knee problems. It is characterized by pain in the front of the knee that is aggravated by deep knee flexion, prolonged sitting, and repetitive movement. The most widely accepted theory regarding the source of this pain is that a force imbalance around the knee puts extra stress on the area, leading to pain. * Researchers are interested in learning more about the muscle groups around the knee to better understand the causes of knee pain. Objectives: \- To obtain more information on how muscles, tendons, and bones work together to cause motion in the knee, both in the normal state and after immobilizing certain muscles around the knee. Eligibility: \- Healthy individuals between the ages of 18 and 55, who have no current or chronic muscle, bone, or joint problems and who have no implants or other problems that would prevent them from receiving a magnetic resonance imaging (MRI) scan. Design: * This protocol will be carried out over two visits, both of which will involve using standard MRI sequences to look at the knee at rest and in motion. * The first part will examine the knee under its natural state, with a standard MRI scan of the knee both at rest and in motion. * The second part will involve temporarily reducing the force producing capabilities of one of the extensor muscles in the knee. To do so, study doctors will inject lidocaine into the muscle, which will temporarily (for approximately 2 hours) block the force producing capacity of this muscle, and then perform the MRI scan.

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2009-10-22

What the Registry Record Tells You About NCT00978003

The ClinicalTrials.gov registry entry for NCT00978003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00978003 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00978003 about?

NCT00978003 is a clinical study titled "Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteer". Background: * Patellofemoral pain syndrome is one of the most common knee problems. It is characterized by pain in the front of the knee that is aggravated by deep knee flexion, prolonged sitting, and repetitive movement. The most widely accepted theory regarding the source of this pain is that a f...

What is the current status of trial NCT00978003?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2009-10-22.

Who is sponsoring clinical trial NCT00978003?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.